Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chi Van Dang

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Biomolecules & Therapeutics|December 8, 2017
Convergence of Cancer Metabolism and Immunity: an OverviewChi Van Dang, Jung-Whan Kim
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 29, 2022
Translational Cancer Research Priorities and the Role of Molecular Imaging: A Conversation Between Chi Van Dang, Elizabeth Jaffee, and David MankoffChi Van Dang, Elizabeth Jaffee, David Mankoff
The Lancet. Oncology|January 22, 2021
Cancer Moonshot 2.0David B Agus, Elizabeth M Jaffee, Chi Van Dang
Science Advances|February 13, 2021
Time-of-day specificity of anticancer drugs may be mediated by circadian regulation of the cell cycleYool Lee, Shi Yi Fong, Joy Shon, et al.
Metabolites|July 30, 2016
Deciphering the Duality of Clock and Growth Metabolism in a Cell Autonomous System Using NMR Profiling of the SecretomeArjun Sengupta, Saikumari Y Krishnaiah, Seth Rhoades, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 24, 2008
Nuclear MYC protein overexpression is an early alteration in human prostate carcinogenesisBora Gurel, Tsuyoshi Iwata, Cheryl M Koh, et al.
Leukemia|September 29, 2023
Chimeric kinase ALK induces expression of NAMPT and selectively depends on this metabolic enzyme to sustain its own oncogenic functionQian Zhang, Johnvesly Basappa, Hong Y Wang, et al.
Cancer Immunology Research|November 2, 2022
The AACR Journals: Advancing Progress Toward the AACR's 115-Year MissionKenneth C Anderson, Lewis C Cantley, Riccardo Dalla-Favera, et al.
Molecular Cancer Therapeutics|November 3, 2022
The AACR Journals: Advancing Progress Toward the AACR's 115-Year MissionKenneth C Anderson, Lewis C Cantley, Riccardo Dalla-Favera, et al.
Blood Cancer Discovery|November 2, 2022
The AACR Journals: Advancing Progress Toward the AACR's 115-Year MissionKenneth C Anderson, Lewis C Cantley, Riccardo Dalla-Favera, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Biomolecules & Therapeutics|December 8, 2017
Convergence of Cancer Metabolism and Immunity: an OverviewChi Van Dang, Jung-Whan Kim
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 29, 2022
Translational Cancer Research Priorities and the Role of Molecular Imaging: A Conversation Between Chi Van Dang, Elizabeth Jaffee, and David MankoffChi Van Dang, Elizabeth Jaffee, David Mankoff
The Lancet. Oncology|January 22, 2021
Cancer Moonshot 2.0David B Agus, Elizabeth M Jaffee, Chi Van Dang
Science Advances|February 13, 2021
Time-of-day specificity of anticancer drugs may be mediated by circadian regulation of the cell cycleYool Lee, Shi Yi Fong, Joy Shon, et al.
Metabolites|July 30, 2016
Deciphering the Duality of Clock and Growth Metabolism in a Cell Autonomous System Using NMR Profiling of the SecretomeArjun Sengupta, Saikumari Y Krishnaiah, Seth Rhoades, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 24, 2008
Nuclear MYC protein overexpression is an early alteration in human prostate carcinogenesisBora Gurel, Tsuyoshi Iwata, Cheryl M Koh, et al.
Leukemia|September 29, 2023
Chimeric kinase ALK induces expression of NAMPT and selectively depends on this metabolic enzyme to sustain its own oncogenic functionQian Zhang, Johnvesly Basappa, Hong Y Wang, et al.
Cancer Immunology Research|November 2, 2022
The AACR Journals: Advancing Progress Toward the AACR's 115-Year MissionKenneth C Anderson, Lewis C Cantley, Riccardo Dalla-Favera, et al.
Molecular Cancer Therapeutics|November 3, 2022
The AACR Journals: Advancing Progress Toward the AACR's 115-Year MissionKenneth C Anderson, Lewis C Cantley, Riccardo Dalla-Favera, et al.
Blood Cancer Discovery|November 2, 2022
The AACR Journals: Advancing Progress Toward the AACR's 115-Year MissionKenneth C Anderson, Lewis C Cantley, Riccardo Dalla-Favera, et al.
Pageof 3